New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial​

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial​

RSS » New York Times News » NYTHealth

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial​

December 12, 2025

11HS-obesity-arthritis-wcqj-mediumSquareAt3X-qArUBL-rss

 The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.  

Creator: The New York Times (NYTHealth)

Source URL

Related Posts

  • Ecosystems and Health
Wildlife Habitat Protection in a Rapidly Changing World
Wildlife Habitat Protection
  • Energy & Infrastructure
Energy Independence Solutions for a More Resilient Future
Energy Independence Solutions
  • Outbreaks and Emerging Issues
Ebola Spillover Risk and the Growing Threat of Outbreaks
Ebola Spillover Risk

Most Recent

  • Book and Article Reviews
One Health Book Review: A Comprehensive Analysis 
One Health Book Review
  • Careers
Value of MPH in One Health: Career Benefits and Impact
Value of MPH in One Health
  • Community Stories
Malaria Control Strategies: One Health in Action
Malaria Control Community Stories

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts